Cardiac disease is common in dogs — mitral valve disease (MVD) is the most prevalent cardiac condition, affecting virtually all Cavalier King Charles Spaniels by age 10 and many other small breeds. Dilated cardiomyopathy (DCM) affects large and giant breeds including Dobermans, Boxers, Great Danes, and Irish Wolfhounds. The evidence-based supplement approach to cardiac support in dogs centers primarily on omega-3 fatty acids, taurine, and coenzyme Q10.

Omega-3 (EPA+DHA): the most evidence-supported cardiac supplement

The American College of Veterinary Internal Medicine (ACVIM) consensus statement specifically recommends omega-3 supplementation for dogs with cardiac disease. The documented benefits:

• Anti-arrhythmic: EPA and DHA stabilize cardiac myocyte membranes, reducing ventricular arrhythmia frequency in dogs with DCM — the arrhythmia that causes sudden death in Dobermans with DCM
• Cardiac muscle support: DHA is a structural component of cardiac muscle cell membranes; adequate DHA status supports contractile function
• Anti-inflammatory: EPA-derived SPMs reduce the systemic inflammatory environment that accelerates cardiac remodeling in chronic heart failure
• Appetite and cachexia: Cardiac cachexia (muscle wasting from heart failure) is partially mediated by inflammatory cytokines; omega-3 at therapeutic dose reduces cachexia severity

Dose: 40–55mg combined EPA+DHA per pound of body weight daily. For a 70-lb Doberman, that's 2800–3850mg EPA+DHA — often 3–4 standard fish oil capsules or a high-concentration marine oil supplement. Marine-sourced only; plant omega-3 doesn't provide EPA/DHA directly.

Taurine

Taurine deficiency has been associated with DCM in certain breeds (Golden Retrievers, Newfoundlands, Irish Setters) and in dogs fed grain-free diets high in legumes (the "BEG diet DCM" controversy). Taurine supplementation reverses DCM in deficiency-related cases. If your dog has been diagnosed with DCM on a grain-free diet, taurine levels should be tested and supplementation considered as directed by a cardiologist.

Coenzyme Q10 (CoQ10)

CoQ10 is an electron carrier in mitochondrial energy production and a fat-soluble antioxidant. In cardiac muscle, which has extraordinarily high mitochondrial density, CoQ10 status affects contractile efficiency. Some human cardiac studies show benefit; canine-specific evidence is limited but CoQ10 has a favorable safety profile. Dose: 30–100mg depending on dog size, with a fat-containing meal for absorption.

Breed-specific cardiac supplement guidance

Cavalier King Charles Spaniels (MVD): Omega-3 + CoQ10 from early adulthood. ACVIM Stage B1/B2 MVD: omega-3 is specifically recommended in the consensus guidelines.

Doberman Pinschers (DCM/ARVC): Omega-3 at maximum therapeutic dose from 2–3 years of age; Holter monitor screening from 3 years is the ACVIM recommendation for this breed.

Boxers (ARVC): Omega-3 for arrhythmia support; be cautious with quercetin at very high doses (mild cardiac ion channel effects) — standard allergy formula doses are considered safe.

Taurine-deficiency suspect breeds on grain-free: Test taurine levels; supplement under veterinary guidance if deficient.

Related: omega-3 dosing guide · Doberman guide · Cavalier guide · senior dog guide.